The access to medical imaging is still limited for Indigenous and non-Indigenous population in remote communities. Teleradiology is now the standard of practice due to the small population size and the large geographical area to cover. The process of teleradiology is quite complex as it requires a very good coordination between the local and remote […]

The access to medical imaging is still limited for Indigenous and non-Indigenous population in remote communities. Teleradiology is now the standard of practice due to the small population size and the large geographical area to cover. The process of teleradiology is quite complex as it requires a very good coordination between the local and remote […]

I will examine the limits of evolution by investigating morphological and genetic variation of threespine stickleback populations in real time, under the supervision of Dr. Eric Palkovacs at the University of California, Santa Cruz. According to evolutionary theory, organisms experience selective pressures, which can result in adaptation and evolution. Since strong selection events are frequently […]

Le syndrome d’apnées du sommeil touche un milliard de personnes dans le monde et est associé à des pathologies cardiovasculaires et métaboliques telles que l’insuffisance coronarienne et le diabète de type 2. Chez la femme ménopausée, la prévalence et les conséquences du SAS augmentent. Les équipes du Pr. Joseph et du Dr Belaïde utilisent l’hypoxie […]

Breast?conserving surgery (BCS) is a mainstay in breast cancer treatment. For nonpalpable breast cancers, current strategies have limited accuracy, contributing to high tumor-positive margin rates. Perk-Lab developed NaviKnife, a surgical navigation system based on real?time electromagnetic (EM) tracking. The goal of the research project is to confirm the further feasibility of intraoperative EM navigation in […]

Over the last several decades, challenges in the development, production, supply, and use of vaccines have been raised and by consequence had led to increasing concern around the world. As a result, an increase in research and innovation in the vaccine industry is needed. In this sense, one of the most critical factors in the […]

Over the last several decades, challenges in the development, production, supply, and use of vaccines have been raised and by consequence had led to increasing concern around the world. As a result, an increase in research and innovation in the vaccine industry is needed. In this sense, one of the most critical factors in the […]

Single domain antibodies (sdAbs) represent a versatile class of heavy chain antibodies lacking a paired light chain and encoded by VHH germline genes typically expressed in camelids. KisoJi Biotech has developed a transgenic mouse line in which each mouse expresses multiple camelid VHH genes capable of specifically binding any antigen of interest. The small molecular […]

Single domain antibodies (sdAbs) represent a versatile class of heavy chain antibodies lacking a paired light chain and encoded by VHH germline genes typically expressed in camelids. KisoJi Biotech has developed a transgenic mouse line in which each mouse expresses multiple camelid VHH genes capable of specifically binding any antigen of interest. The small molecular […]

A wide range of cognitive faculties are commonly compromised in numerous trauma-exposed populations, leading to impaired functioning, and reduced treatment response rates. There is a dire need for novel therapies that can directly target such deficits in top-down cognitive control. Goal management training (GMT) is one such cognitive remediation therapy found to be effective for […]

Sudden Unexpected Death in Epilepsy (SUDEP), the commonest cause of death in epilepsy, is the most feared complication. SUDEP usually occurs following a seizure, most often in patients who are non-responsive to antiepileptic drugs. These patients are typically found dead in bed following respiratory apnea and cardiac arrest. Our group has shown that seizures in […]

Immunotherapies are transforming conventional cancer treatments with significant improvement of patient survival rates. FDA-approved immunotherapies (immune checkpoint inhibitors, ICIs) have shown remarkable success in the treatment of hematologic malignancies but very low response rate in patients with solid tumors. Therefore, there is an urgent need for novel therapies against solid malignancies. Cura Therapeutics is developing […]